Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3.74x is 34% above its 5-year average of -5.64x, around the middle of its 5-year range (-10.36x–-0.71x).
27.30% below its 12-month average of -2.94x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -0.71x.
INTEREST COVERAGE RATIO
-3.74x
INTEREST COVERAGE RATIO AVG TTM
-2.94x
INTEREST COVERAGE RATIO AVG 3Y
-4.34x
INTEREST COVERAGE RATIO AVG 5Y
-5.64x
INTEREST COVERAGE RATIO AVG 10Y
-5.66x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.30%
CURRENT VS 3Y AVG
+13.86%
CURRENT VS 5Y AVG
+33.64%
CURRENT VS 10Y AVG
+33.90%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+41.93%
vs the sector median at left
Neuronetics, Inc.
Market Cap
$153.79M
Interest Coverage Ratio
-3.74x
TTM Avg
-2.94x
3Y Avg
-4.34x
5Y Avg
-5.64x
Market Cap
$153.58M
Interest Coverage Ratio
-1.03x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$156.22M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
Market Cap
$151.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$149.36M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.73M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.64M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$159.14M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuronetics, Inc. (STIM) | $153.79M | -3.74x | -2.94x | -4.34x | -5.64x |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | -1.03x | N/A | N/A | N/A |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.22M | N/A | 2247.41x | 1131.54x | 905.57x |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | N/A | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | -64.93x | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | N/A | N/A | N/A | N/A |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | -19.95x | 6.75x | 6.75x | 6.75x |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -5.64x | N/A | N/A | N/A |
Interest Coverage
-3.7x
Debt/Equity
4.85
Current Ratio
1.88
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -0.71x |
| 2026-03-31 | -3.97x |
| 2025-12-31 | -2.40x |
| 2025-09-30 | -3.52x |
| 2025-06-30 | -4.09x |
| 2025-03-31 | -5.73x |
| 2024-12-31 | -7.17x |
| 2024-09-30 | -4.48x |
| 2024-06-30 | -4.30x |
| 2024-03-31 | -3.76x |
| 2023-12-31 | -2.40x |
| 2023-09-30 | -7.49x |
| 2023-06-30 | -6.42x |
| 2023-03-31 | -7.91x |
| 2022-12-31 | -6.38x |
| 2022-09-30 | -7.03x |
| 2022-06-30 | -9.80x |
| 2022-03-31 | -10.36x |
| 2021-12-31 | -6.49x |
| 2021-09-30 | -7.23x |
| 2021-06-30 | -6.72x |
| 2021-03-31 | -7.01x |
| 2020-12-31 | -2.63x |
| 2020-09-30 | -2.42x |
| 2020-06-30 | -6.96x |
| 2020-03-31 | -6.81x |
| 2019-12-31 | -7.67x |
| 2019-09-30 | -6.80x |
| 2019-06-30 | -7.10x |
| 2019-03-31 | -7.68x |
| 2018-12-31 | -6.03x |
| 2018-09-30 | -4.67x |
| 2018-06-30 | -5.82x |
| 2018-03-31 | -5.00x |
| 2017-12-31 | -5.72x |
| 2017-09-30 | -3.48x |
| 2017-06-30 | -3.62x |
| 2017-03-31 | -7.25x |
